Search results
Mario Natalino Concetto Amendola (8 December 1910 – 22 December 1993) was an Italian screenwriter, film director and dramatist. Biography. Amendola was born in Recco, which is located in Genova to parents from Rome. He began his career on stage in 1931 as a writer for avanspettacolo shows.
SCIENTIFIC PRODUCTION. 25 articles in peer-reviewed journals: 24 research papers (4 as first author), 1 review as first author; . 2 manuscripts in revision. 8 patents + 2 in preparation. Cumulative citations index: 4791; H index: 22.
Consultez le profil de Mario Amendola sur LinkedIn, une communauté professionnelle d’un milliard de membres. The research in my laboratory focuses on the development of new gene therapy...
- 1.3K
- INSERM
Mario Amendola is an Associate Professor of Molecular Biology at the University of Foggia and a Team Leader at Genethon. He has a Ph.D. in Molecular Medicine from San Raffaele Hospital and has worked at the Netherlands Cancer Institute, HSR-TIGET and Salk Institute.
Jul 18, 2019 · Mario AMENDOLA. CR 1 INSERM, Group Leader “Therapeutic genome editing” Genethon, Evry, FRANCE. Monday 1 July 2019 | 12:00 noon. Ex vivo editing of HSC for erythroid- specific expression of therapeutic proteins. Host: A. Muro.
Mario Amendola, PhD. Guillaume Corre, PhD. The team’s projects. Current projects are focused on several themes: Develop new strategies to safely and efficiently integrate vectors and donor DNA using CRISPR-Cas9.
People also ask
How is Dr Amendola?
When did Amendola become a writer?
Who was Amendola and what did he do?
Who is Adam Amendola?
We propose here improvements developed today, including by French researchers to overcome the editing-related genotoxicity and improve editing precision by the use of novel recombinant nuclease-based systems such as nickases, base editors, and prime editors.
